Skip to main content
SpringerLink
Log in

Treatment of Multiple Sclerosis

Trial Design, Results, and Future Perspectives

  • Book
  • © 1992

Overview

Editors:
  1. Richard A. Rudick

    1. Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic Foundation, Cleveland, USA

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  2. Donald E. Goodkin

    1. Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic Foundation, Cleveland, USA

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

Part of the book series: Clinical Medicine and the Nervous System (CLIN.MED.NERV.)

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (15 chapters)

  1. Front Matter

    Pages i-xviii
    Download chapter PDF

  2. Experimental Therapies for Multiple Sclerosis: Historical Perspective

    • George W. Ellison
    Pages 1-15

  3. The Natural History of Multiple Sclerosis

    • Donald E. Goodkin
    Pages 17-45

  4. Assessing the Outcome of Experimental Therapies in Multiple Sclerosis Patients

    • Donald Paty, Ernest Willoughby, John Whitaker
    Pages 47-90

  5. Design and Statistical Issues Related to Testing Experimental Therapy in Multiple Sclerosis

    • William Weiss, Emanuel M. Stadlan
    Pages 91-122

  6. Pathogenesis of Multiple Sclerosis: Relationship to Therapeutic Strategies

    • Richard M. Ransohoff
    Pages 123-133

  7. Treatment of Multiple Sclerosis with ACTH and Corticosteroids

    • Lawrence W. Myers
    Pages 135-156

  8. Treatment of Multiple Sclerosis with Azathioprine

    • Richard A. C. Hughes
    Pages 157-172

  9. Treatment of Multiple Sclerosis with Copolymer I

    • Murray B. Bornstein, Kenneth P. Johnson
    Pages 173-198

  10. Treatment of Multiple Sclerosis with Cyclophosphamide

    • Glenn A. Mackin, David M. Dawson, David A. Hafler, Howard L. Weiner
    Pages 199-216

  11. Treatment of Multiple Sclerosis with Cyclosporine A

    • Jerry S. Wolinsky
    Pages 217-232

  12. Treatment of Multiple Sclerosis with Interferons

    • Lawrence Jacobs, Frederick Munschauer
    Pages 233-250

  13. Treatment of Multiple Sclerosis with Plasma Exchange

    • John H. Noseworthy
    Pages 251-266

  14. Total Lymphoid Irradiation in Multiple Sclerosis

    • Stuart D. Cook, Corinne Devereux, Raymond Troiano, Christine Rohowsky-Kochan, Amiram Sheffet, Annette Jotkowitz et al.
    Pages 267-279

  15. Specific Immunotherapeutic Strategies: Lessons from Myelin Basic Protein-Induced Experimental Allergic Encephalomyelitis

    • Robert B. Bell, Lawrence Steinman
    Pages 281-299

  16. Experimental Approaches to Specific Immunotherapy in Multiple Sclerosis

    • David A. Hafler, Staley A. Brod, Howard L. Weiner
    Pages 301-307

  17. Back Matter

    Pages 309-313
    Download chapter PDF
Back to top

Keywords

About this book

Multiple sclerosis is one of the major current problems in neurol­ ogical practice. It remains incompletely understood, yet is a common cause of chronic disability in developed Western so­ cieties: Patients with the disease have difficulty understanding what has happened to them and become bewildered by the con­ trast between the evidently large body of knowledge concerning the clinical manifestations and course of the disease, and the conflicting views they so often receive from different specialists as to the best current management of their disease. As in so many disorders for which treatment is only partially effective, at best, "alternative" therapies abound. Dr. Rudick and Dr. Goodkin have extensive experience in the day-to-day management of multiple sclerosis at the Mellen Center for Multiple Sclerosis Treatment and Research, attached to the Cleveland Clinic. In this book they have assembled a group of experts from several countries and have provided a comprehensive review of the results of different treatments of the disease. Each treatment is considered in the light of its proposed scientific basis or mode of action, and in relation to ethical and trial design issues. This information deserves to be made widely available. As the treatment of multiple sclerosis enters a new era as a result of the new understanding of the cellular mechanisms of demyelination and the molecular biology of the immune response, this information about current treatments assumes additional importance. The book is of interest to all physicians concerned with the management of patients with the disease.

Editors and Affiliations

  • Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic Foundation, Cleveland, USA

    Richard A. Rudick, Donald E. Goodkin

Bibliographic Information

Publish with us

Policies and ethics

Back to top

Search

Navigation